A recent observational cohort suggests the luxury fitness chain's newly installed hypoxic vapor rooms are highly associated with rapid depletion of disposable income, though experts caution more research is needed to determine any cardiovascular benefit.
Equinox announced the rollout of the experimental protocol at its Hudson Yards location on Tuesday, introducing a sealed glass enclosure that simulates Himalayan atmospheric pressure while pumping in aerosolized essential oils. However, public health officials immediately warned that the self-reported wellness benefits of breathing thin, mentholated air while paying a tier-four premium have not yet been evaluated in double-blind clinical trials.
A preliminary paper published this week in JAMA Internal Medicine noted a strong correlation between chamber usage and subsequent large-scale credit authorizations. Researchers stressed that the data remains inconclusive, as the sudden drop in participants' net worth could be confounded by other lifestyle variables, such as proximity to the facility's $40 activated-charcoal smoothie bar.
While early trials indicate a robust willingness among members to tap their flexible spending accounts while experiencing mild hypoxia, the actual physiological mechanisms remain poorly understood.
The NIH has since announced a longitudinal study to observe whether the subset of members paying for the high-altitude chamber experience any distinct biological outcomes compared to a control group breathing regular locker-room air for free.
Until the findings are formally peer-reviewed, regulatory agencies advise consumers that current guidance does not support substituting established aerobic exercise with highly monetized aromatherapy.